To study HLA-E-mediated inhibition of NK cell cytotoxicity, we induced HLA-E expression in four different solid tumor cell lines: the human breast adenocarcinomas MDA-MB-231 and SK-BR-3, the lung carcinoma A549, and the colorectal adenocarcinoma HT-29. The gene discussed is HLA-E; the disease is breast adenocarcinoma.